Biotech

All Articles

Lilly posts much more good data on its own once a week the hormone insulin possibility

.On the heels of an FDA turndown for its main competing Novo Nordisk, Eli Lilly is actually pushing ...

IN 8bio halts stage 2 trial, gives up fifty percent of labor force

.Merely a handful of months after dosing the very first individual in a period 2 test for recently i...

Lilly, Haya ink $1B biobuck being overweight contract to look darker genome

.Eli Lilly's search for obesity targets has actually led it to the dark genome. The Big Pharma has p...

ArsenalBio raises $325M, pivots away from past lead possession

.Arsenal Biosciences is actually moving on up. The cell treatment provider has added $325 million in...

Lilly- backed weight management biotech data IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...

Aelis' cannabis use medicine flunks period 2b, driving Indivior to re-think $100M choice

.Aelis Farma's chances of securing a quick, positive choice on a $100 million alternative remittance...

ProKidney stops period 3 test not needed to have for cell treatment confirmation

.ProKidney has actually quit one of a set of phase 3 trials for its tissue therapy for renal conditi...

Vaxcyte climbs on 'impressive' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what experts referred to as "remarkable" period 1/2 records for its 31-valent pneu...

Recursion's brain disease test shows little proof of effectiveness

.Recursion has actually discovered through an early examination of its own tech-enabled method to me...

Acepodia, Pfizer click all together for chemistry-based cell therapy

.Call it a case of excellent chemical make up: Acepodia, a biotech based on Nobel Prize-winning scie...